Repare Therapeutics continues climb following Roche licensing deal; shares up 40%

Retrieved on: 2022-06-02 18:59:33

Tags for this article:

Click the tags to see associated articles and topics

Repare Therapeutics continues climb following Roche licensing deal; shares up 40%. View article details on hiswai:

Excerpt

Repare Therapeutics (RPTX) is continuing to benefit Thursday from a licensing deal with Roche (RHHBY) announced after the closing bell Wednesday.

Article found on: seekingalpha.com